Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Dolby Laboratories (DLB) Total Current Liabilities (2016 - 2025)

Dolby Laboratories (DLB) has disclosed Total Current Liabilities for 17 consecutive years, with $443.5 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Total Current Liabilities changed 0.37% year-over-year to $443.5 million, compared with a TTM value of $443.5 million through Dec 2025, changed 0.37%, and an annual FY2025 reading of $437.8 million, up 4.78% over the prior year.
  • Total Current Liabilities was $443.5 million for Q4 2025 at Dolby Laboratories, up from $437.8 million in the prior quarter.
  • Across five years, Total Current Liabilities topped out at $457.5 million in Q1 2025 and bottomed at $277.5 million in Q3 2022.
  • Average Total Current Liabilities over 5 years is $364.5 million, with a median of $371.7 million recorded in 2024.
  • The sharpest move saw Total Current Liabilities skyrocketed 52.14% in 2023, then decreased 16.19% in 2024.
  • Year by year, Total Current Liabilities stood at $283.3 million in 2021, then grew by 2.53% to $290.4 million in 2022, then surged by 35.69% to $394.1 million in 2023, then rose by 12.12% to $441.9 million in 2024, then rose by 0.37% to $443.5 million in 2025.
  • Business Quant data shows Total Current Liabilities for DLB at $443.5 million in Q4 2025, $437.8 million in Q3 2025, and $388.8 million in Q2 2025.